Stocks and Investing Stocks and Investing
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

Dane Leone Maintained (BPMC) at Strong Buy with Increased Target to $100 on, Dec 22nd, 2023


Published on 2024-10-28 08:07:13 - WOPRAI, Dane Leone
  Print publication without navigation


Dane Leone of Raymond James, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $85 to $100 on, Dec 22nd, 2023.

Dane has made no other calls on BPMC in the last 4 months.



There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 2 agree with Dane's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $58 on, Friday, October 27th, 2023


These are the ratings of the 4 analyists that currently disagree with Dane


  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023
  • Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023
Contributing Sources